Complete Filing Data
TAKEDA PHARMACEUTICAL CO LTD reported Cash And Cash Equivalents of $385.11 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean TAKEDA PHARMACEUTICAL CO LTD did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | -$3.99B | $6.47B | -$8.63B | -$15.37B | $76.0M | -$23.99B | -$43.63B | -$32.20B | -$1.55B |
| Share Of Other Comprehensive Income Of Associates And Joint Ventures Accounted For Using Equity Method That Will Be Reclassified To Profit Or Loss Net Of Tax | -$145.0M | -$1.79B | -$892.0M | -$497.0M | -$299.0M | -$181.0M | -$94.0M | $382.0M | -$38.0M |
| Research And Development Expense | $730.23B | $729.92B | $633.33B | $526.09B | $455.83B | $492.38B | $368.30B | $325.44B | $312.30B |
| Profit Loss From Operating Activities | $342.59B | $214.08B | $490.51B | $460.84B | $509.27B | $100.41B | $237.69B | $241.79B | $155.87B |
| Profit Loss Before Tax | $175.08B | $52.79B | $375.09B | $302.57B | $366.24B | -$60.75B | $127.61B | $217.21B | $143.35B |
| Profit Loss Attributable To Owners Of Parent | $107.93B | $144.07B | $317.02B | $230.06B | $376.01B | $44.24B | $135.19B | $186.89B | $114.94B |
| Profit Loss Attributable To Noncontrolling Interests | $215.0M | $130.0M | $21.0M | $107.0M | $166.0M | $49.0M | -$112.0M | -$178.0M | $573.0M |
| Profit Loss | $108.14B | $144.20B | $317.04B | $230.17B | $376.17B | $44.29B | $135.08B | $186.71B | $115.51B |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net Of Tax | -$19.36B | -$2.69B | $15.10B | $6.16B | $66.73B | -$9.91B | -$5.67B | $724.0M | $15.55B |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net Of Tax | -$146.48B | $997.70B | $579.44B | $588.10B | $254.51B | -$233.80B | -$7.82B | $55.23B | -$37.93B |
| Other Comprehensive Income Net Of Tax Hedging Cost | $7.96B | $7.20B | -$16.99B | $2.46B | -$9.15B | -$857.0M | -$4.91B | $1.61B | -$222.0M |
| Other Comprehensive Income Net Of Tax Gains Losses On Remeasurements Of Defined Benefit Plans | -$7.05B | -$5.00B | $17.75B | $20.78B | $4.87B | -$6.40B | -$11.67B | $724.0M | $15.55B |
| Other Comprehensive Income Net Of Tax Exchange Differences On Translation | -$153.35B | $968.84B | $618.77B | $583.97B | $309.30B | -$207.07B | $30.98B | $46.61B | -$51.82B |
| Other Comprehensive Income Net Of Tax Cash Flow Hedges | -$956.0M | $23.46B | -$21.45B | $2.17B | -$45.35B | -$25.69B | -$33.79B | $1.92B | $4.63B |
| Other Comprehensive Income | -$165.84B | $995.01B | $594.54B | $594.26B | $321.25B | -$243.71B | -$13.49B | $55.96B | -$22.37B |
| Income Taxes Refund Classified As Operating Activities | $20.18B | $17.90B | $12.47B | $7.30B | $34.11B | $7.84B | $6.63B | $24.99B | $12.48B |
| Income Taxes Paid Classified As Operating Activities | $170.59B | $219.94B | $198.44B | $147.72B | $235.80B | $234.61B | $51.54B | $54.87B | $53.23B |
| Income Tax Expense Continuing Operations | $66.94B | -$91.41B | $58.05B | $72.41B | -$9.94B | -$105.04B | -$7.47B | $30.50B | $27.83B |
| Impairment Loss | $106.53B | $150.02B | $64.39B | $54.52B | $25.45B | $101.88B | $10.12B | $13.54B | $51.36B |
| Cost Of Sales | $1.58T | $1.43T | $1.24T | $1.11T | $994.31B | $1.09T | $651.73B | $495.92B | $558.76B |
| Comprehensive Income Attributable To Owners Of Parent | -$57.85B | $1.14T | $911.53B | $824.26B | $697.20B | -$199.57B | $121.86B | $242.44B | $93.55B |
| Comprehensive Income Attributable To Noncontrolling Interests | $154.0M | $173.0M | $45.0M | $168.0M | $214.0M | $150.0M | -$264.0M | $220.0M | -$410.0M |
| Comprehensive Income | -$57.70B | $1.14T | $911.57B | $824.43B | $697.42B | -$199.42B | $121.60B | $242.66B | $93.14B |
| Adjustments For Income Tax Expense | $66.94B | -$91.41B | $58.05B | $72.41B | -$9.94B | -$105.04B | -$7.47B | $30.50B | $27.83B |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $385.11B | $457.80B | $533.53B | $849.70B | $966.22B | $637.61B | $702.09B | $294.52B | $319.46B | $451.43B |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $200.80B | $175.42B | $140.66B | $123.25B | $111.21B | $127.08B | $77.68B | $67.01B | $61.66B | |
| Purchase Of Investments | $97.54B | $6.77B | $10.15B | $8.34B | $12.60B | $7.55B | $17.10B | $16.88B | $12.11B | |
| Purchase Of Intangible Assets Classified As Investing Activities | $147.05B | $305.31B | $493.03B | $62.79B | $125.26B | $90.63B | $56.44B | $61.26B | $50.37B | |
| Other Inflows Outflows Of Cash Classified As Operating Activities | -$10.11B | -$7.56B | -$88.78B | $41.41B | $37.79B | $15.36B | -$69.34B | $20.81B | $12.33B | |
| Other Inflows Outflows Of Cash Classified As Investing Activities | -$1.11B | -$4.00B | -$3.05B | -$7.33B | -$10.34B | -$14.13B | -$7.57B | $13.01B | -$20.39B | |
| Other Inflows Outflows Of Cash Classified As Financing Activities | -$16.65B | -$26.10B | -$9.18B | -$385.0M | -$172.0M | -$3.89B | -$14.33B | -$4.08B | -$4.93B | |
| Issue Of Equity | $36.18B | $502.0M | $164.0M | $22.15B | $44.0M | $49.08B | $3.13T | $25.32B | $874.0M | |
| Increase Decrease Through Transfers And Other Changes Equity | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Gains Losses On Disposals Of Property Plant And Equipment | -$4.50B | -$6.05B | -$10.0M | -$655.0M | $2.11B | $990.0M | $45.22B | $434.0M | $129.0M | |
| Expense From Equitysettled Sharebased Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets | $72.87B | $70.87B | $60.67B | $43.37B | $37.66B | $29.12B | $20.08B | $18.61B | $15.39B | |
| Cash Flows From Used In Operations | $1.21T | $918.38B | $1.16T | $1.26T | $1.21T | $896.52B | $373.39B | $407.74B | $302.11B | |
| Cash Flows From Used In Operating Activities | $1.06T | $716.34B | $977.16B | $1.12T | $1.01T | $669.75B | $328.48B | $377.85B | $261.36B | |
| Cash Flows From Used In Investing Activities | -$367.06B | -$463.86B | -$607.10B | -$198.13B | $393.53B | $292.12B | -$2.84T | -$93.34B | -$655.69B | |
| Cash Flows From Used In Financing Activities | -$751.43B | -$354.42B | -$709.15B | -$1.07T | -$1.09T | -$1.01T | $2.95T | -$326.23B | $289.90B | |
| Cash Flows From Losing Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | $20.56B | $19.96B | $7.96B | $28.20B | $530.39B | $461.55B | $85.13B | $85.08B | $64.41B | |
| Amortisation Intangible Assets Other Than Goodwill | $643.23B | $652.12B | $542.44B | $472.92B | $421.86B | $455.42B | $178.62B | $122.13B | $156.72B | |
| Adjustments For Increase Decrease In Trade And Other Payables | -$7.12B | -$9.90B | -$84.80B | $125.16B | $36.62B | -$29.93B | -$16.41B | $6.86B | $42.56B | |
| Adjustments For Decrease Increase In Trade And Other Receivables | -$58.96B | $15.10B | $75.13B | $127.29B | -$9.32B | -$34.83B | -$13.38B | -$647.0M | -$37.32B | |
| Intangible Assets Other Than Goodwill | $3.63T | $4.27T | $4.27T | $3.82T | $3.91T | $4.17T | $4.75T | $1.01T | ||
| Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | $0.00 | $0.00 | $49.67B | $0.00 | $4.89B | $2.96T | $28.33B | $589.14B |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | $78.0M | $8.61B | $962.0M | $1.82B | $46.45B | $12.58B | $50.72B | $2.97B | $2.63B |
| Proceeds From Sale Of Investments | $29.44B | $8.02B | $22.25B | $16.92B | $74.60B | $49.40B | $65.04B | $40.74B | $5.27B |
| Proceeds From Payments For Short Term Borrowings | $27.49B | $277.00B | $40.00B | -$2.0M | -$149.04B | -$351.22B | $367.32B | -$403.93B | $406.97B |
| Proceeds From Borrowings Classified As Financing Activities | $1.02T | $100.00B | $75.00B | $249.33B | $1.18T | $496.19B | $2.80T | $393.45B | $260.23B |
| Payments To Acquire Or Redeem Entitys Shares | 51.86B | 2.33B | 26.93B | 77.53B | 2.14B | 3.74B | 1.17B | 18.76B | 23.12B |
| Increase Decrease In Contingent Consideration Asset Liability | -$602.0M | $20.76B | $3.99B | -$11.20B | $59.28B | -$18.39B | -$5.97B | $10.52B | -$18.44B |
| Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes | -$61.30B | -$101.93B | -$339.09B | -$145.29B | $316.11B | -$43.34B | $439.02B | -$41.71B | -$104.43B |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -$11.39B | $26.20B | $22.93B | $28.76B | $12.50B | -$21.77B | -$31.27B | $4.57B | $5.74B |
| Payments Of Lease Liabilities Classified As Financing Activities | $45.17B | $54.59B | $43.40B | $39.69B | $39.27B | $30.00B | $1.74B | $2.66B |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Diluted Earnings Loss Per Share | $67.23 | $91.16 | $201.94 | $145.87 | $238.96 | $28.25 | $139.82 | $237.56 | $146.26 |
| Basic Earnings Loss Per Share | $68.36 | $92.09 | $204.29 | $147.14 | $240.72 | $28.41 | $140.61 | $239.35 | $147.15 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Repayments Of Borrowings Classified As Financing Activities | $1.32T | $320.90B | $356.67B | $810.12B | $1.65T | $701.06B | $0.00 | $140.00B | $191.76B |
| Purchase Of Treasury Shares | 51.93B | 2.37B | 27.07B | 79.45B | 2.14B | 52.75B | 1.17B | 41.55B | 23.12B |
| Other Income | $26.21B | $19.38B | $25.42B | $43.12B | $318.02B | $60.21B | $159.86B | $169.41B | $143.53B |
| Noncurrent Provisions | $35.18B | $14.37B | $55.97B | $52.20B | $38.75B | $37.61B | $25.16B | $28.04B | $38.11B |
| Miscellaneous Other Operating Expense | $206.73B | $206.53B | $145.25B | $159.08B | $258.90B | $248.69B | $103.16B | $126.56B | $72.88B |
| Interest Received Classified As Investing Activities | $17.66B | $11.16B | $5.05B | $2.92B | $1.11B | $11.49B | $6.31B | $2.41B | $2.00B |
| Interest Paid Classified As Financing Activities | $112.98B | $100.38B | $108.56B | $108.21B | $107.35B | $127.21B | $34.91B | $8.37B | $6.97B |
| Increase Decrease Through Transactions With Owners | -$280.33B | -$219.87B | -$242.59B | -$318.08B | -$247.73B | -$258.57B | $3.02T | -$174.22B | -$155.38B |
| Increase Decrease Through Sharebased Payment Transactions | $74.71B | $69.84B | $62.67B | $43.37B | $37.66B | $29.12B | $20.10B | $18.61B | $15.32B |
| Increase Decrease Through Exercise Of Share Based Payment Transactions | -$36.13B | -$77.0M | -$42.0M | -$13.97B | $502.0M | -$1.18B | -$7.88B | $453.0M | $738.0M |
| Finance Income | $46.55B | $52.09B | $62.91B | $23.70B | $105.52B | $27.83B | $16.84B | $39.54B | $12.27B |
| Finance Costs | $210.07B | $219.85B | $169.70B | $166.61B | $248.63B | $165.01B | $83.29B | $31.93B | $23.25B |
| Dividends Received Classified As Investing Activities | $635.0M | $13.19B | $3.56B | $3.40B | $387.0M | $1.38B | $2.74B | $7.70B | $3.67B |
| Dividends Paid Classified As Financing Activities | $302.50B | $287.19B | $279.42B | $283.67B | $283.36B | $282.58B | $142.95B | $141.89B | $141.69B |
| Dividends Paid | $303.16B | $287.79B | $278.31B | $284.25B | $283.80B | $282.85B | $142.87B | $144.31B | $143.71B |
| Depreciation And Amortisation Expense | $761.40B | $728.00B | $664.40B | $583.15B | $559.67B | $583.65B | $247.69B | $182.13B | $171.43B |
| Current Provisions | $533.14B | $524.42B | $508.36B | $443.50B | $471.28B | $405.25B | $387.13B | $132.78B | $135.80B |
| Changes In Other Provisions | -$45.17B | $126.90B | -$31.90B | $58.09B | -$49.10B | -$21.94B | -$47.06B | $6.53B | -$20.55B |
| Cancellation Of Treasury Shares | 0.00 | 1.0M | 1.0M | 1.0M | 2.0M | 1.0M | 3.0M | 1.0M | 4.0M |
| Administrative Expense | $1.10T | $1.05T | $997.31B | $886.36B | $875.66B | $964.74B | $717.60B | $628.11B | $619.06B |
| Adjustments For Decrease Increase In Inventories | -$34.97B | -$115.74B | -$79.16B | -$46.15B | $25.98B | $137.49B | $50.72B | $13.72B | $3.89B |
| Adjustments For Finance Income Cost | -$163.52B | -$167.76B | -$106.79B | -$142.91B | -$143.11B | -$137.18B | -$66.45B | $7.62B |
Most recent annual filing with the SEC: June 25, 2025
Data sourced from SEC EDGAR public filings as of August 4, 2026.